bacil-pharmaBacil Pharma Ltd.

₹43+0.00%

Market Cap

₹0.00 Cr

Stock P/E

0.00

ROCE

0.00%

ROE

0.00%

Book Value

₹0.00

You might have missed

No Recent News

No recent news available for this stock.

Shareholding

Holdings

Distribution

Promoter

Public

Others

From Last Concall

No Concall Summary

Conference call summary is not available for this stock.

Peers Summary

Sector Laggard

Bacil Pharma Ltd. is significantly lagging behind its peers in key financial metrics such as revenue growth, profitability, and efficiency. With a PE ratio of 124.55 and no reported revenue or profit margins, it is not positioned favorably compared to the more established competitors in the pharmaceuticals sector.

Key Points

• Bacil Pharma Ltd. reported 0% revenue growth YoY and 3-Year, indicating stagnation.
• The company has a very high PE ratio of 124.55 with no returns on equity (ROE = 0).
• Compared to peers, Bacil Pharma is underperforming on profitability metrics and carries no debt.

Top Performers

Sun Pharmaceutical Industries Ltd.

Highest revenue growth (YoY 8.42%) and strong profitability with ROE of 16.13%.

Cipla Ltd.

Strong growth trajectory with 13.28% revenue growth YoY and a low PE ratio of 23.73.

Dr. Reddy's Laboratories Ltd.

Consistent profitability metrics with ROE of 21.76% and a low PE ratio of 15.50.

Explore

Watchlists

Command Palette